Restarting Duloxetine After Brief Discontinuation
Restart duloxetine at 30 mg once daily for one week, then increase to 60 mg once daily. This is the standard initiation protocol recommended to minimize nausea and other adverse effects, and should be followed even when restarting after a brief interruption 1.
Rationale for Gradual Restart
The evidence strongly supports using the initial titration schedule rather than immediately resuming the full 60 mg dose:
Guideline-based dosing: Multiple guidelines consistently recommend starting duloxetine at 30 mg once daily for 1 week before increasing to 60 mg once daily 1. This approach reduces the most common adverse effect—nausea—which occurs more frequently with abrupt initiation at higher doses.
Discontinuation syndrome considerations: Duloxetine is associated with discontinuation symptoms when stopped abruptly 2. After a treatment gap, the patient's system has cleared the medication, effectively resetting their tolerance. Research shows that 44.3% of patients experience discontinuation-emergent adverse events when duloxetine is stopped, with dizziness (12.4%) and nausea (5.9%) being most common 3.
Loss of tolerance: When antidepressants are interrupted and restarted, there's a documented risk of reduced responsiveness (4-57% non-response rate) 4. Starting at the lower dose helps re-establish tolerance while minimizing adverse effects that could compromise adherence.
Specific Dosing Algorithm
Week 1: Duloxetine 30 mg once daily
Week 2 onward: Duloxetine 60 mg once daily (her previous maintenance dose)
Important Clinical Considerations
Do not use alternate-day dosing: Some clinicians mistakenly recommend every-other-day dosing when restarting, but this approach causes pronounced receptor occupancy fluctuations and significantly increases withdrawal symptom risk 5. Duloxetine has a sufficiently long half-life for once-daily dosing 2.
Monitor closely during restart: Watch for:
- Nausea, dizziness, headache (most common side effects during initiation)
- Behavioral activation, anxiety, or mood changes (particularly in first 1-4 weeks) 6
- Blood pressure and pulse (SNRIs can cause modest increases) 2
Timing matters: The duration of her discontinuation isn't specified, but any gap longer than a few days warrants restarting at 30 mg. Research on discontinuation shows most symptoms resolve within 7 days, but the physiological reset justifies cautious reinitiation 3.
Counsel about adherence: Emphasize the importance of continuous use once restarted. Intermittent adherence reduces antidepressant effectiveness and may explain treatment failures 4. If she needed to stop previously, address barriers to adherence before restarting.
Alternative Consideration
If the patient previously tolerated 60 mg well and the discontinuation was very brief (≤3-4 days), you could consider restarting at 60 mg directly, but this increases the risk of nausea and other adverse effects. The safer, evidence-based approach remains the 30 mg × 1 week titration, which adds minimal delay while substantially improving tolerability 1, 7.